长期护理机构居民停用降压药与心血管事件
该比较效果研究采用目标试验模拟,利用美国退伍军人事务部社区生活中心2006年10月1日至2019年9月30日收治的65岁及以上长期护理机构居民电子健康记录数据,纳入至少服用1种降压药者。暴露为降压药数量减少或剂量降低≥30%,主要终点为2年内因心肌梗死或卒中住院。13 096名居民中17.8%在12周内停用降压药;经IPTW和IPCW调整后,停用降压药与心梗或卒中住院无关联(HR 0.93;95%CI 0.70-1.26)。作者认为这些发现可能为考虑停用降压药的长期护理机构居民和临床医生提供信息。
要点
- 在13 096名长期护理机构居民中,17.8%在12周内停用降压药(药物数量减少或剂量降低≥30%)。
- 2年内卒中或心梗住院的未调整累积发生率:停用降压药者11.2% vs 未停用者8.8%,差值2.4个百分点(95%CI -2.3至7.1个百分点)。
- 经IPTW和IPCW充分调整后,停用降压药与心梗或卒中住院无关联(HR 0.93;95%CI 0.70-1.26)。
- 应用IPTW和IPCW后参与者特征均衡,所有标准化均数差均小于0.05。
- 作者认为,这些发现可能为考虑停用降压药的长期护理机构居民和临床医生提供信息。
适用人群与场景
- 年龄65岁及以上、至少服用1种降压药、2006年10月1日至2019年9月30日收治于美国退伍军人事务部社区生活中心的长期护理机构居民。
- 97.4%为男性;中位年龄77岁(IQR 70-84岁)。
诊断标准与关键阈值
- 暴露定义:降压药数量减少或剂量降低≥30%,通过条形码给药数据评估。
研究设计与关键结果
- 研究设计:比较效果研究,采用目标试验模拟,使用观察性电子健康记录数据;分析于2023年8月至2024年8月进行。
- 样本量:13 096名长期护理机构居民;17.8%在12周内停用降压药。
- 主要终点:2年内因心肌梗死或卒中住院,使用ICD-9和ICD-10编码评估。
- 未调整累积发生率:停用降压药者11.2% vs 未停用者8.8%,差值2.4个百分点(95%CI -2.3至7.1个百分点)。
- 经IPTW和IPCW调整后,停用降压药与心梗或卒中住院无关联(HR 0.93;95%CI 0.70-1.26)。
- 应用IPTW和IPCW后参与者特征均衡,所有标准化均数差均小于0.05。
证据类型、等级与局限
- 证据类型:比较效果研究(目标试验模拟,观察性电子健康记录数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现可能为考虑停用降压药的长期护理机构居民和临床医生提供信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The practice of deprescribing antihypertensive medications is common among long-term care residents, yet the effect on cardiovascular outcomes is unclear.
OBJECTIVE: To compare the incidence of hospitalization for myocardial infarction (MI) or stroke among long-term care residents who are deprescribed or continue antihypertensive therapy.
DESIGN, SETTING, AND PARTICIPANTS: This comparative effectiveness research study used target trial emulation with observational electronic health record data from long-term care residents aged 65 years or older admitted to US Department of Veterans Affairs community living centers between October 1, 2006, and September 30, 2019, and taking at least 1 antihypertensive medication. Analyses were conducted between August 2023 and August 2024.
EXPOSURE: A reduction in the number of antihypertensive medications or dose (by ≥30%), assessed using barcode medication administration data.
MAIN OUTCOME AND MEASURES: Incidence of MI and stroke hospitalization up to 2 years was assessed using International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes. A pooled logistic regression model with inverse probability of treatment weighting (IPTW) and inverse probability of censoring weighting (IPCW) was used to estimate per-protocol effects.
RESULTS: Of 13 096 long-term care residents (97.4% men; median age, 77 years [IQR, 70-84 years]) taking antihypertensive medication, 17.8% were deprescribed antihypertensive medication over a period of 12 weeks. The estimated unadjusted cumulative incidence of stroke or MI hospitalization over 2 years was similar among residents who were and were not deprescribed antihypertensives in per-protocol analyses (11.2% vs 8.8%; difference, 2.4 percentage points [95% CI, -2.3 to 7.1 percentage points]). Participant characteristics were balanced after applying IPTW and IPCW; all standardized mean differences were less than 0.05. After full adjustment for confounding and informative censoring, the per-protocol analysis results showed no association of antihypertensive deprescribing with MI or stroke hospitalization (hazard ratio, 0.93; 95% CI, 0.70-1.26).
CONCLUSIONS AND RELEVANCE: In this comparative effectiveness research study, deprescribing antihypertensive medication was not associated with risk of hospitalization for MI or stroke in long-term care residents. These findings may be informative for long-term care residents and clinicians who are considering deprescribing antihypertensive medications.
参考来源
- Odden MC, Graham LA, Liu X, et al. Antihypertensive Deprescribing and Cardiovascular Events Among Long-Term Care Residents. JAMA Netw Open. 2024. PMID: 39585693. doi:10.1001/jamanetworkopen.2024.46851
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。